Skip to content

Creatinine

by Beckman Coulter Inc. 2 variants

Ref OSR6178

Creatinine (OSR6178) is a creatinine IVD (EU IVDR Class B; FDA Class II; FDA product code CGX, Alkaline Picrate, Colorimetry, Creatinine) made by Beckman Coulter, Inc., registered in EUDAMED on 30 Jun 2022 (Basic UDI-DI 150995901OSR6178MQ), cleared under FDA 510(k) K924692 on 19 Oct 1992 and listed in FDA GUDID since 24 Sep 2016 (UDI-DI 15099590010737), active as of 22 Oct 2026. One FDA recall is linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE IVDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None ongoing

1 closed

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K924692

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number150995901OSR6178MQ Basic UDI-DI 15099590010737UDI-DIDate30 Jun 2022RegisteredStatusActive
United StatesGUDID listing GUDID Number15099590010737 UDI-DI Date24 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK924692 Date19 Oct 1992DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 150995901OSR6178MQ registered 30 Jun 2022 Active
  • FDA 510(k) K924692 decided 19 Oct 1992 Active
  • FDA GUDID UDI-DI 15099590010737 listed 24 Sep 2016 Listed

Recalls

1 recall · FDA

    • Terminated Z-0958-2013 FDA Class II initiated 28 Dec 2012

    Beckman Coulter is including additional information and instructions in the Creatinine (OSR6x78) IFU and Setting Sheet, relating to calibration stability and quality control frequency to assure product performance.

Timeline

4 dated events

  1. Cleared FDA 510(k) K924692
  2. Recall initiated FDA recalls Z-0958-2013
  3. Listed FDA GUDID 15099590010737
  4. Registered EUDAMED 150995901OSR6178MQ

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Creatinine EUDAMED
Au GUDID
Generic name
Creatinine IVD, kit, spectrophotometry
Model / reference
OSR6178
Primary DI / UDI-DI
15099590010737
Basic UDI-DI
150995901OSR6178MQ
510(k) Number
FDA product code
CGX
EMDN code
W01019099 Clinical chemistry reagents - other
GMDN term
Creatinine IVD, kit, spectrophotometry
Device class
Class B EUDAMED
Class II GUDID
Regulation number
862.1225
EU registration type
Standard device
EU market of registration
Ireland
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class B
GUDID
Class II

Device class is stated on each registry's own scale: Class B in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Manufacturer details

EUDAMED SRN
US-MF-000010288
Authorised representative
Beckman Coulter Ireland Inc. IE-AR-000000886

Similar devices in this category

Other devices filed under CLINICAL CHEMISTRY REAGENTS - OTHER.

Other devices from Beckman Coulter, Inc.

See all devices from Beckman Coulter, Inc. →

Properties

  • Single use
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (17, all answered No)